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Neuropathic pain results from damage to the peripheral sensory nervous system, which may have a number of causes. The calcium
channel subunit 2-1 is upregulated in dorsal root ganglion (DRG) neurons in several animal models of neuropathic pain, and this is
causally related to the onset of allodynia, in which a non-noxious stimulus becomes painful. The therapeutic drugs gabapentin and
pregabalin (PGB), which are both 2 ligands, have antiallodynic effects, but their mechanism of action has remained elusive. To
investigate this,weusedan in vivo ratmodel of neuropathy, unilateral lumbar spinal nerve ligation (SNL), to characterize thedistribution
of2-1 inDRGneurons, both at the light- and electron-microscopic level.We found that, on the side of the ligation,2-1was increased
in the endoplasmic reticulum of DRG somata, in intracellular vesicular structures within their axons, and in the plasma membrane of
their presynaptic terminals in superficial layers of the dorsal horn. Chronic PGB treatment of SNL animals, at a dose that alleviated
allodynia, markedly reduced the elevation of 2-1 in the spinal cord and ascending axon tracts. In contrast, it had no effect on the
upregulation of 2-1 mRNA and protein in DRGs. In vitro, PGB reduced plasma membrane expression of 2-1 without affecting
endocytosis. We conclude that the antiallodynic effect of PGB in vivo is associated with impaired anterograde trafficking of 2-1,
resulting in its decrease in presynaptic terminals, which would reduce neurotransmitter release and spinal sensitization, an important
factor in the maintenance of neuropathic pain.
Introduction
Neuropathic pain results from nerve damage, which may have
several different origins, including trauma, diabetes, herpes in-
fection, and cancer. Its phenotype involves hyperalgesia, allo-
dynia, and spontaneous pain (Dickenson et al., 2002). There are
several well established animal models of neuropathic pain in-
cluding unilateral spinal nerve ligation (SNL) (Kim and Chung,
1992; Bennett et al., 2003), in which a plethora of genes change
their expression in the damaged dorsal root ganglion (DRG) neu-
rons (Costigan et al., 2002; Wang et al., 2002). These changes
include a significant upregulation of the calcium channel acces-
sory subunit 2-1 (for review, see Davies et al., 2007). Increased
expression has been observed for2-1mRNA inDRGs (Newton
et al., 2001; Wang et al., 2002) and for 2-1 protein, in both the
affected ganglia and the spinal cord dorsal horn (Li et al., 2004).
This increase of2-1 coincides with the onset of tactile allodynia
(Li et al., 2004).
Evidence that elevation of the 2-1 subunit has significant
relevance to the development of neuropathic pain is first that
mice globally overexpressing2-1 exhibit tactile allodynia in the
absence of nerve damage (Li et al., 2006). Second, the antiallo-
dynic and antihyperalgesic gabapentinoid drugs pregabalin
(PGB) and gabapentin are of important therapeutic benefit in the
treatment of neuropathic pain and have been shown to be 2
ligands (Brown et al., 1998; Field et al., 2006). Third, knock-in
mice expressing amutant 2-1 subunit that does not bind gaba-
pentinoids develop neuropathic pain that is insensitive to these
drugs (Field et al., 2006). Nevertheless, to date, no molecular
mechanism has been put forward to account for the ability of
these drugs to alleviate neuropathic pain in vivo.
Voltage-gated calcium channels of the CaV1 and CaV2 classes
can be purified as heteromeric complexes consisting of an 1
subunit, associated with a  and an 2 subunit (for review, see
Catterall, 2000; Dolphin, 2003). The principal effect of calcium
channel 2 subunits is to increase the functional expression of
these channels (Jones et al., 1998; Qin et al., 1998; Wyatt et al.,
1998; Barclay et al., 2001; Klugbauer et al., 2003), as a conse-
quence of increased trafficking (Cantí et al., 2005). Recently, we
showed that gabapentin only produces a substantial inhibition of
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calcium currents when applied chronically but not acutely in
vitro, by reducing the expression of CaV1 and 2 subunits at
the plasma membrane (PM) (Hendrich et al., 2008). We con-
cluded that gabapentin is an inhibitor of calcium channel
trafficking.
In the present study, we used a rat model of neuropathic pain
(lumbar L5/L6 SNL) to test our hypothesis that gabapentinoid
drugs inhibit the trafficking of 2-1 from DRG cell bodies to
their presynaptic terminals in the dorsal horn of the spinal cord.
We analyzed the distribution of2-1 inDRGs, axons, and spinal
cord in the ligated L5/L6 region comparedwith the nonligated L4
region, both at the light- and electron-microscopic (EM) level,
and we determined the effect of chronic PGB treatment on 2-1
distribution.We found that chronic PGB treatment at a dose that
alleviated neuropathic pain also inhibited the anterograde traf-
ficking of 2-1 subunits.
Materials andMethods
Nerve injury-selective (L5/6) spinal nerve ligation. A total of 48 male
Sprague Dawley rats (Central Biological Services, University College
London, London, UK) weighing 130–150 g at time of surgery was used
for this study. All experimental procedures were approved by the United
Kingdom Home Office and followed the guidelines of the International
Association for the Study of Pain (Zimmermann, 1983). Selective SNL
surgery was conducted as previously described (Kim and Chung, 1992).
Briefly, the left L5 and L6 spinal nerves were isolated and tightly ligated
with 6-0 silk thread under isoflurane anesthesia (50% O2/50% N2O).
Hemostasis was confirmed and thewoundwas sutured. Shamoperations
were performed in the same way except that spinal nerves were not
ligated. After surgery, the animals were allowed to recover and housed at
a maximum of five per cage. Food and water were available ad libitum.
The foot posture and general behavior of the operated rats were moni-
tored throughout the postoperative period. Animals with impaired mo-
tor activity were omitted from this study.
Drug administration. PGB (a gift from Pfizer) was dissolved in 0.9%
saline solution to give a dose of 30 mg/kg. After recovery from surgery,
rats were divided into two groups and randomly assigned to receive
either PGB or saline injections (SNL plus PGB or SNL plus saline, respec-
tively). All injections were administered subcutaneously in the scruff of
the back of the neck. Beginning on postoperative day 1, rats were given
three daily injections of either PGB or saline until postoperative day 9
when the animals were culled 1 h after the second injection. Animals used
to investigate the accumulation of2-1 at the ligation sidewere killed on
postoperative day 4.
Behavioral observations. Behavioral responses to mechanical and
cooling stimulation of the ipsilateral and contralateral hindpaws were
recorded preoperatively and postoperatively on days 3, 2, 4, 7, and
9 and conducted 1 h after a PGB injection. Briefly, animals were left to
acclimatize to the area for 30 min before testing. Sensitivity to me-
chanical punctate stimulation (response frequency) was assessed
through the measurement of the number of foot withdrawal re-
sponses to a trial of 10 applications of calibrated hand-held von Frey
filaments with increasing bending force of 2, 6, and 8 g corresponding
to 19.6, 58.9, and 78.5 mN (Touch-Test; North Coast Medical) to
the plantar surface of each hindpaw. Sensitivity to cooling stimulation
was similarly assessed as the number of withdrawals of a trial of five
applications of a drop of acetone to the plantar surface of ipsilateral
and contralateral hindpaws. Response frequency was quantified as the
number of foot withdrawals per 10 or 5 trials, respectively. The dose
of PGB used in the present study (30 mg/kg, s.c.) has been reported
not to produce any sedative effects (Field et al., 2001). To assess
possible sedative effects of the multiple dosing regimen, performance
on a rotarod (Ugo Basile model 7750; Linton Instruments) was also
recorded. The apparatus was set to accelerate from 0 to 20 rpm over
60 s and the time maintained on the beam before falling was recorded
(with a maximum cutoff of 150 s). Only rats scoring between 60 and
120 s in the two training sessions before surgery were used for exper-
imentation. Spinal nerve ligation itself had no adverse effect on the
rotarod performance when compared with sham-operated rats [time
on the rotarod 3 d before surgery: SNL, 93 9 s (n 14); sham, 90
8 s (n 11); time on the rotarod 7 d after surgery: SNL, 62 14 s (n
14); sham, 76  10 s (n  11)]. The statistical significance of differ-
ences between data was determined using the nonparametric Mann–
Whitney U test (GraphPad Prism 4.0). The level of significance was
set to *p  0.05.
Quantitative PCRand immunoblotting.For quantitative PCR (Q-PCR)
and immunoblot assays, the methods used were essentially as described
previously (Davies et al., 2006; Donato et al., 2006). Briefly, RNA was
extracted from individual ipsilateral or contralateral L4 or pooled L5 and
L6 pulverized frozen DRGs, 7–14 d after ligation or 14 d after sham
surgery and from ipsilateral or contralateral DRGs obtained from SNL
plus PGB- or SNL plus saline-injected animals. RNA was also extracted
from ipsilateral and contralateral spinal cord dorsal horn tissue 4 d after
SNL. RNA was isolated using RNeasy columns (QIAGEN), including an
on-column DNase step. Reverse transcription was performed on 1 g of
RNA using the iScript kit with random primers (Bio-Rad). Q-PCR was
performed with an iCycler (Bio-Rad) using the iQ SYBR supermix (Bio-
Rad). For each set of primers and for every experiment, a standard curve
was generated using a serial dilution of reverse-transcribedRNA from the
combined samples. Data were normalized for expression of glyceraldehyde-3-
phosphatedehydrogenase(GAPDH)mRNA.Datafromtheipsilateralsidewere
thennormalizedtotheirrespectivecontralateral side, ifnotstatedotherwise,and
given as themean SEM. Statistical significance between sham, 7 or 14 d SNL
andSNLplus salineandSNLplusPGBconditionsof ipsi (56)or ipsi 4DRGs
was determined by a one-way ANOVA test with Student–Newman–Keuls
(SNK)posttest(GraphPadPrism).DatafromQ-PCRonspinalcordtissuewere
normalized to the 2-1 mRNA level in contralateral L5 DRGs measured in
parallel, andstatistical significancewasdeterminedbyStudent’snonpaired t test.
The following Q-PCR primers were used: rat GAPDH (AF_106860), 5-
ATGACTCTACCCACGGCAAG-3, 5-CATACTCTGCACCAGCATCTC-
3; rat 2-1 (NM_012919), 5-AGCCTATGTGCCATCAATTAC-3, 5-AG-
TCATCCTCTTCCATTTCAAC-3; rat 2-2 (NM_175592), 5-CAGT-
GGTGGGTGTCAAAC-3, 5-TACCTCGCAGTCCATCTC-3; rat 2-3
(NM_175595), 5-TCCGAACGCACCATCAAG-3 (forward), 5-ACTGT-
CCACCACCACCAT-3 (reverse).
For immunoblotting, proteins were extracted from 1mm spinal nerve
segments, complete DRGs, and 8–10 mm dorsal root segments pooled
from two to four animals in a buffer of PBS with 1 mM EDTA in the
presence of protease inhibitors (Complete; Roche Diagnostics) by soni-
cation (2–3 s) followed by incubation with 0.2% SDS and 1% Igepal for
40 min on ice. After centrifugation (30 min at 14,000 g at 4°C), 14 g
of protein per sample were loaded onto a 3–8% NuPage Tris/acetate gel
(Invitrogen), and proteins were separated by SDS-PAGE. Proteins were
transferred to poly(vinylidene difluoride) membranes (Bio-Rad) and,
after blocking (500mMNaCl, 10mMTris, pH 7.4, with 3%BSA and 0.5%
Igepal), were probed with the mouse monoclonal anti-dihydropyridine
receptor (2-1 subunit) antibody (1:1000; Sigma-Aldrich) at room tem-
perature (RT) overnight or with the mouse monoclonal anti-GAPDH
antibody (1:37,500; Ambion) for 1 h. The protein–antibody complexes
were then labeled with a horseradish peroxidase-conjugated secondary
antibody (1:2000; Sigma-Aldrich) for 1 h at RT and detected using the
enhanced ECL Plus reagent (GE Healthcare) visualized with a Typhoon
9410 scanner (GEHealthcare). Quantification of immunoblot bandswas
performed with ImageQuant software (GE Healthcare).
Immunocytochemistry. To validate the specificity of the mouse mono-
clonal anti-dihydropyridine receptor (2-1 subunit) antibody (Sigma-
Aldrich), Cos-7 cells were transfected with either rat 2-1 (AF_286488)
or mouse 2-2 (AF_247139) in conjunction with rat 1b (X61394) and
rabbit CaV2.2 (D14157) as described previously (Page et al., 2004). The
immunocytochemical detection of 2-1 was performed as described
previously (Cantí et al., 2005). Briefly, extracellular immunoreactivity
was detected by incubating nonpermeabilized cells with mouse anti-
2-1 antibody (1:100) in growth medium for 1 h at 37°C. Cells were
fixed with 4% paraformaldehyde in PBS for 5 min at RT. For labeling of
intracellular epitopes, cells were permeabilized for 15 min with 0.02%
Triton X-100 in Tris-buffered saline (TBS); for nonpermeabilized cells,
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this step was omitted. All cells were then blocked for at least 30 min in
TBS with 20% goat serum (GS) and 4% BSA and incubated with the
anti-2-1 antibody (1:100) at 4°C overnight. Samples were then washed
and incubatedwith biotinylated goat anti-mouse IgG (1:500; Invitrogen)
for 2 h at RT followed by streptavidin-Alexa Fluor 488 (1:500; Invitro-
gen) for 1 h at RT. After washing andDNA staining with 4,6-diamidino-
2-phenylindole (DAPI) (300 nM; Invitrogen), samples were mounted in
VectaShield (Vector Laboratories). To test for cross-reactivity, perme-
abilized cells expressing 2-2 were incubated with a mixture of the
mouse monoclonal anti-2-1 antibody (1:100) and a rabbit polyclonal
anti-2-2 antibody [2-2 (107–117); 0.55 g/ml] (Brodbeck et al.,
2002) at 4°C overnight. The primary antibodies were recognized with
biotinylated goat anti-mouse IgG and streptavidin-Alexa Fluor 488 or
with anti-rabbit-Texas Red antibody (Invitrogen). Immunofluorescence
labeling was detected with a LSM 510Meta (Zeiss) confocal microscope.
Experiments were performed on at least two individual transfections.
To investigate the effect of PGB on cell surface expression of 2-1, 20
or 200MPGBdissolved in 0.9% salinewas added to the growthmedium
at the time of transfection. An equal volume of saline was added to
control cells. The extracellular immunoreactivity was then detected in
nonpermeabilized cells as described above.
Endocytosis of 2-1 in Cos-7 cells coexpressing 2-1, CaV2.2, and
1b, 72 h after transfection and incubation in absence or presence of 200
M PGB was measured by labeling cells with the mouse monoclonal
anti-2-1 antibody (1:150) at 37°C for 2.5 h (with PGB present when
required). Cells were then fixed, and cell surface 2-1 subunits were
detected in the absence of permeabilization with a Texas Red-conjugated
secondary antibody (1:100)mixedwith a nonlabeled secondary antibody
(1:500) for saturation. The cells were then permeabilized with 0.02%
TritonX-100 and internalized antibodywas detectedwith anAlexa Fluor
488-conjugated secondary antibody (1:500). Images were acquired as
described above. Experiments were performed on three individual
transfections.
Immunohistochemistry. Rats were deeply anesthetized with an intra-
peritoneal injection of (600 mg/kg) pentobarbitone (Euthatal; Merial
Animal Health), perfused transcardially with saline containing heparin
followed by perfusion with 4% paraformaldehyde in 0.1 M phosphate
buffer (PB), pH 7.4. Ipsilateral and contralateral L4–6 DRGs with the
adjacent spinal nerve and dorsal root, L4–6 lumbar and upper cervical
spinal cord, and the brainstem were dissected out. The tissue was post-
fixed for 1.5–2 h, washed with PB, cryoprotected by incubation in PB
with 15% sucrose overnight, and finally frozen before sectioning with a
cryostat. DRGs were sectioned to a thickness of 10mand spinal cord to
15 m. For immunofluorescence labeling, a modification of a method
described previously was used (Li et al., 2006). Sections underwent heat-
induced antigen retrieval (10mM citrate buffer, pH 6.0, 0.05%Tween 20,
95°C for 10 min) before blocking with 10% GS in the presence of 0.1%
Triton X-100 in PBS for 1 h. To detect 2-1, sections were incubated
with the mouse monoclonal anti-2-1 antibody (1:100) in 50% blocking
buffer for 40 h at 4°C. After extensive washing with PBS containing 0.1%
TritonX-100, sections were incubatedwith biotinylated goat anti-mouse
IgG (1:500) for 2 h at RT and streptavidin-Alexa Fluor 488 (1:500) for 1 h
at RT. After extensive washing and DNA staining with DAPI, samples
weremounted in VectaShield (Vector Laboratories). For immunoperox-
idase staining, endogenous peroxidase was blocked with 3%H2O2 for 30
min before antigen retrieval. Sections were blocked using the Vectastain
Elite ABC kit (Vector Laboratories), incubated with the primary and
secondary antibody (ABC kit) for 2 h followed by 1 h incubation with the
avidin–biotin complex (ABC kit). Peroxidase activity was detected with
diaminobenzidine according to the manufacturer’s protocol (Vector
Laboratories). After extensive washing, samples were dehydrated,
cleared, andmounted inDPX (distyrene, plasticizer, and xylene) (Sigma-
Aldrich). All experiments were performed on frozen sections with the
exception of paraffin-embedded sections shown in Figure 2. For paraffin
embedding, tissue was dehydrated in ethanol, treated with Histoclear
(Thermo Fisher Scientific), and infiltrated with paraffin (VWR) at 65°C
overnight. Paraffin blocks were sectioned on a microtome at 10 m
thickness. Sections were then deparaffinized and rehydrated, and under-
went immunoperoxidase staining as described above. The anatomical
position of the brainstem sections is based on the rat atlas of Paxinos and
Watson (2005). The immunohistochemical staining of 2-1 in dorsal
roots (see Fig. 5) was performed on intact tissue. Dorsal roots were re-
moved 2–7 d after ligation and fixed in 4% PFA in 0.1 M PB for 2 h
followed by washing in PB and incubation in PB with 15% sucrose over-
night. The tissue then underwent heat-induced antigen retrieval before
blocking with 10% GS in the presence of 0.1% Triton X-100 in PBS for
1 h. To detect 2-1, the tissue was incubated with the mouse monoclo-
nal anti-2-1 antibody (1:100) in 50% blocking buffer for 48 h at 4°C.
After extensive washing with PBS containing 0.1% Triton X-100, the
tissue was incubated with biotinylated goat anti-mouse IgG (1:500) for
24 h at 4°C and streptavidin-Alexa Fluor 488 (1:500) for 4 h at RT. After
extensive washing and DNA staining with DAPI, samples were mounted
in VectaShield (Vector Laboratories).
Experiments were performed on at least two individual rats.
Image acquisition and analysis. Immunoperoxidase staining was visu-
alized on a Leica MZ7.5 stereomicroscope with a DC300 camera under
transmitted light using the Leica IM50 software (Leica). To quantify
2-1 staining in the fasciculus gracilis in saline- or PGB-injected ani-
mals, RGB color images were transformed into gray level images using
ImageJ software (http://rsb.info.nih.gov/ij), and gray level density was
measured in a triangular region of interest overlaying the ipsilateral and
contralateral side, respectively. Ipsilateral gray level density was then
normalized to the contralateral side (100%). All data are given as the
mean  SEM. Statistical significance between SNL plus saline and SNL
plus PGB sections was determined with Student’s nonpaired t test.
To quantify levels of 2-1 staining in nonpermeabilized Cos-7 cells,
optical sections of 4.1 m thickness with constant photomultiplier set-
tings were acquired midway through the cell in the z-axis. Fluorescence
density was measured in a region of interest by outlining each individual
cell using ImageJ. Fluorescence densities in PGB-treated cells were nor-
malized to the mean value measured in saline-treated control cells. Im-
ages of endocytosis of 2-1 shown in Figure 6, I and J, are single 1 m
optical sections taken at the level of the flattened plasmamembrane of the
Cos-7 cells, and therefore the surface immunofluorescence appears as an
annulus, rather than a sharply defined ring. To analyze endocytosis,
Z-stacks with 1 m optical sections were acquired. Regions of interest
within cell outlines were defined, and the fluorescence density within this
region was measured for each individual excitation channel per section.
The amount of protein internalized was defined as the ratio of average
fluorescence density in the green channel (labeling procedure as above)
and the sum of the average fluorescence densities in the green plus red
channels. Results per section were then summarized for each cell.
For the quantitative analysis of fluorescence staining in immunohis-
tochemical sections of DRG cell bodies, at least four nonconsecutive
sections (minimum distance, 120 m) were imaged per ganglion. Opti-
calZ-stacks of 18 images (optical thickness, 1m)were acquired sequen-
tially with constant nonsaturated photomultiplier settings. All cells
within the visual field were subject to analysis, but only cells with an
intact nucleus that was visible at its widest diameter in the stack were
actually used. Using ImageJ, stacks were transformed into gray level
Z-projections and the cell area andmean fluorescence density (FD) [flu-
orescence intensity in arbitrary units (a.u.) per squaremicrometer] from
two representative regions of interest per cell measured. Fifty to 80 cells
perDRGwere analyzed. Cells were grouped according to their size (New-
ton et al., 2001) into three different types: small, 700 m2; medium,
700–1100 m2; and large, 	1100 m2. Data are given as the mean 
SEM. Statistical significance between the respective ipsilateral and con-
tralateral sides or the ipsilateral sides after different treatments was de-
termined with Student’s nonpaired t test. Statistical significance between
the different size groups within a ganglion was determined with a one-
way ANOVA and Bonferroni’s post test (GraphPad Prism). On spinal
cord sections (optical thickness,	10m), regions of interest (173 588
m) were placed over the ipsilateral and contralateral sides of the dorsal
horn to measure fluorescence intensity plot profiles (FI) [gray levels (in
arbitrary units) with respect to the distance from the surface (in mi-
crometers)]. The ipsilateral and contralateral profiles were normalized to
the maximum value of the contralateral side and themean plot profile of
all sections calculated. Statistical significance was determined with Stu-
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dent’s nonpaired t test [for all statistical tests: ***p 0.001; **p 0.01;
*p 0.05; not significant (ns), p	 0.05].
Immunoelectron microscopy. EM detection of 2-1 immunoreactivity
was performed as previously described using the preembedding immu-
nogold method (Lujan et al., 1996). Briefly, animals were perfused with
4% paraformaldehyde, 0.05% glutaraldehyde, and 15% (v/v) saturated
picric acid in 0.1 M PB. Tissue was postfixed overnight, and coronal slices
of 60 m thickness were cut on a vibratome. Free-floating sections were
blocked in TBS with 10%GS for 1 h at RT and incubated in TBS with 1%
GS and anti-2-1 antibody at 1:100 for 48 h. After washing with TBS,
sections were incubated in TBS with 1% GS and goat anti-mouse IgG
coupled to 1.4 nm gold particles (1:100; Nanoprobes) for 3 h. After
washing with PBS, sections were postfixed with 1% glutaraldehyde in
PBS for 10 min, washed in double-distilled water, followed by a silver
enhancement step of the gold particles with a HQ Silver kit (Nano-
probes). Sections were then treated with osmium tetraoxide (1% in 0.1 M
PB), block-stained with uranyl acetate, dehydrated in a graded series of
ethanol, and flat-embedded on glass slides in Durcupan resin (Fluka;
Sigma-Aldrich). Regions of interest were cut close to the surface of each
block at 70–90 nm on an ultramicrotome (Reichert Ultracut E; Leica)
and collected on 200-mesh nickel grids. The regions were stained with
1% aqueous uranyl acetate followed by Reynolds’s lead citrate. For con-
trols, primary antibodies were either omitted or replaced with 5% (v/v)
normal mouse serum. Under these conditions, no selective labeling was
observed. In addition, some sections were incubated with gold-labeled
secondary antibodies without silver intensification. This resulted in no
metal particles in the sections. Ultrastructural visualization was per-
formed in a Jeol-1010 electron microscope (Jeol). Spinal cord areas were
captured at a finalmagnification of 35,000, whereas images ofDRG cell
bodies and their axons were acquired at 15,000. Immunogold labeling
was quantitatively analyzed on randomly selected 30 ultrathin sections
(10 sections/block; three blocks per animal). The density of immunogold
particles in dendritic shafts and axon terminals in the spinal cord (parti-
cles/100 m2) was calculated from an area of 5000 m2. Approxi-
mately 1000 immunoparticles were analyzed per condition in DRG cell
bodies; immunoparticles were detected in the endoplasmic reticulum
(ER) and at the plasma membrane. The ER density (ER particles/100
m2) was calculated from randomly selected reference areas of 43 m2
covering a total of 1287.9m2. In addition, the number of gold particles
attached to the plasma membrane (PM particles/100 m) was counted.
All DRG somata in the reference area were analyzed. Finally, the density
of labeling in DRG axons (particles/100 m2) was obtained from refer-
ence areas of 43 m2 covering a total of 1287.9 m2 per condition.
Results
Presynaptic increase of2-1 in the superficial and deeper
layers of the ipsilateral dorsal horn after SNL
To examine the elevation of 2-1 in the dorsal horn after SNL,
we first visualized the distribution of 2-1 using immunohisto-
chemical methods. The ipsilateral (on the side of ligation) 2-1
immunoreactivity in L5 spinal cord sections, at 14 d after ligation,
was stronger and extended deeper into the dorsal horn than on
the contralateral side (Fig. 1A; supplemental Figs. 1A,B, 2A,B,
available at www.jneurosci.org as supplemental material). The
contralateral 2-1 immunoreactivity after SNL (supplemental
Fig. 2B, available atwww.jneurosci.org as supplementalmaterial)
showed very similar staining compared with the ipsilateral and
contralateral 2-1 immunoreactivity in L5 spinal cord sections
14 d after sham surgery (supplemental Fig. 2C,D, available at
www.jneurosci.org as supplemental material).
To quantify the distribution of 2-1 in the dorsal horn,
normalized fluorescence intensity profiles of ipsilateral and
contralateral superficial and deeper layers from L4–L6 sec-
tions were created (Fig. 1B; supplemental Fig. 1C–E, available
at www.jneurosci.org as supplemental material). Whereas su-
perficial layers receive input from nociceptive DRG neurons,
the deeper layers are innervated mainly by non-nociceptive
afferents (Woolf and Fitzgerald, 1986). Compared with the
contralateral side at 14 d after SNL, the ipsilateral L5 profile
was 130% higher in the superficial layers of Lissauer’s tract
and lamina I, 65% higher in lamina II (at 100 m depth),
and still significantly increased in the deeper lamina III at 200
m (Fig. 1B). A similar result was found for ipsilateral L6
profiles at 14 d, and L5 profiles at 7 d after ligation (supple-
mental Fig. 1C,D, available at www.jneurosci.org as supple-
mental material). In contrast, ipsilateral L5 profiles at 14 d
after sham surgery did not differ significantly from the con-
tralateral side, at either 100 or 200 m depth (supplemental
Fig. 1E, available at www.jneurosci.org as supplemental mate-
rial). Ipsilateral L4 profiles 14 d after SNL had a25% higher
level of 2-1 immunoreactivity at 100mdepth; however, no
difference was seen in lamina III (Fig. 1B, inset).When imaged
with constant settings, the ipsilateral and contralateral sides of
a L5 spinal cord section, at 14 d after sham surgery, had very
similar intensity profiles compared with the contralateral side
of a L5 spinal cord section 14 d after SNL (supplemental Fig.
2E, available at www.jneurosci.org as supplemental material).
This indicates that SNL had no effect on the expression level of
2-1 in the contralateral side and that 2-1 was only in-
creased in the ipsilateral side after SNL.
We next measured the 2-1 mRNA levels in the dorsal horn
of L5 spinal cord tissue after SNL. For quantification, the 2-1
mRNA level of the ipsilateral and contralateral dorsal horn was
normalized to themRNA levelsmeasured in parallel in contralat-
eral DRGs (100%). Dorsal horn tissue had a lower 2-1
mRNA level than contralateral DRGs, and there was no signifi-
cant difference between the ipsilateral (62  9%; n  9) and
contralateral side (55  5%; n  9; p  0.517, nonpaired Stu-
dent’s t test), indicating that spinal cord neurons are not the
origin of the observed increase of 2-1 protein in the dorsal
horn.
We performed preembedding immunogold EM on ipsilat-
eral (Fig. 1C,D) and contralateral (Fig. 1E,F ) lamina I–III of
L4–L6 spinal cord sections to study the subcellular localiza-
tion of 2-1, at 14 d after ligation. Immunogold particles
were found throughout all sections at the plasmamembrane of
presynaptic nerve terminals of DRG neurons (arrowheads), at
the plasma membrane of postsynaptic dorsal horn neurons
(arrows), and also at intracellular dendritic sites (double ar-
rows). Virtually all the presynaptic 2-1 immunoparticles
were present on excitatory rather than inhibitory terminals,
based on ultrastructural criteria, widely used in the field to
distinguish between glutamatergic and GABA/glycinergic
axon terminals. These criteria include the presence of round
synaptic vesicles in glutamatergic axon terminals and the ex-
istence of a postsynaptic density in the postsynaptic element
(Fig. 1C–F ). Only a single immunoparticle was ever seen over
a (presumed inhibitory) terminal with elliptical vesicles and
no visible postsynaptic density (data not shown).
Whereas the ratio of presynaptic to postsynaptic labeling in
the ipsilateral and contralateral L4 dorsal horn was very similar
(Fig. 1G), the presynaptic labeling was markedly increased in the
ipsilateral L5 (Fig. 1G) and L6 (data not shown) dorsal horn after
SNL. These results show that2-1 is particularly increased in the
plasma membrane of presynaptic nerve terminals at the level of
ligation. Both nociceptive and non-nociceptive afferents seem to
contribute to the elevation, as it is seen both in superficial and in
deeper dorsal horn layers.
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Chronic pregabalin alleviates pain
behavior and reduces the elevation of
2-1 in the superficial layers of the
ipsilateral dorsal horn
Rats were either injected with PGB or sa-
line for 8 d (30 mg/kg, s.c.; three times per
day) starting 1 d after SNL (SNL plus PGB,
SNL plus saline). This chronic PGB treat-
ment significantly reduced paw with-
drawal frequencies tomechanical and cold
stimuli (Fig. 1H; supplemental Fig. 3,
available at www.jneurosci.org as supple-
mental material) and hence reversed tac-
tile and cold allodynia, both symptoms of
ligation-induced neuropathic pain. In
SNL plus saline rats, allodynia was present
from day 2 after SNL, and was maintained
through to day 9, when testing ended. In
contrast, chronic PGB treatment resulted
in significant reductions in paw with-
drawal frequencies, from days 2–9 post-
SNL to 2 and 6 g von Frey filaments (Fig.
1H; supplemental Fig. 3A, available at
www.jneurosci.org as supplemental mate-
rial), and fromdays 4–9 post-SNL to stim-
ulation with the 8 g von Frey filament
(supplemental Fig. 3B, available at
www.jneurosci.org as supplemental mate-
rial). A significant PGB-mediated reduc-
tion in response to acetone cooling
was observed from day 7 after SNL (sup-
plemental Fig. 3C, available at www.
jneurosci.org as supplemental material).
Rotarod testing revealed no sedative side
effects or motor impairment of the injec-
tion regimen (supplemental Fig. 3D, avail-
able at www.jneurosci.org as supplemental
material).
Fluorescence intensity profiles of SNL
plus saline or SNL plus PGB L5 spinal cord
sections (Fig. 1 I) showed that, compared
with saline injections (blue and black
lines), chronic PGB strongly reduced the
ipsilateral ligation-mediated 2-1 immu-
nofluorescence increase (red line) without
affecting the contralateral side (gray line).
A significant PGB-mediated reductionwas
observed in the superficial layers of the
dorsal horn at the level of ligation (Fig. 1 I,
inset). For example, in lamina II of L5 and
L6 sections, whereas the ipsilateral com-
pared with contralateral 2-1 level was
increased by 50 and 75% after saline
injection, this elevation was only25 and
30% after chronic PGB treatment. PGB
had no significant effect on 2-1 levels in
L4 sections (Fig. 1 I, inset) or in deeper lay-
ers of L5/L6 sections (data not shown).
2-1 immunofluorescence is increased
in ipsilateral DRG axons of dorsal roots
The ligation-mediated ipsilateral 2-1
immunofluorescence increase was not re-
Figure 1. Ipsilateral presynaptic increase of 2-1 in the superficial and deeper layers of the dorsal horn after L5/L6 SNL is
reduced by chronic PGB at a dose that alleviated neuropathic pain.A, Representative2-1 immunofluorescence in amontage of
10 images of a transverse L5 spinal cord section 14 d after SNL.2-1 Immunofluorescence, Green; nuclear staining, blue; ipsi,
ipsilateral side (side of ligation); asterisk (*), fold in section; rectangles, regions of interest for fluorescence intensity profiles;
arrow, ipsilateral motor neurons with elevated 2-1 immunofluorescence at the level of ligation. Scale bar, 250 m. B,
Normalized fluorescence intensity profiles (FINORM) of the superficial layers [Lissauer’s tract (Lt), lamina I (I), and lamina II (lam II)
and deeper layers (from lamina III onward)] of the ipsilateral (black line) and contralateral (contra) (gray line) L5 (n 4) and L4
(B, inset; n 11) dorsal horn 14 d after SNL. Profiles are normalized to the contralateral FI maximum. Error bars represent SEM.
For clarity, only error bars at 100 m in lamina II and at 200 m in lamina III are shown. Statistical analysis was as follows:
nonpaired Student’s t test comparing ipsilateral to contralateral side, ***p0.001; *p0.05; ns (not significant),p	0.5.C–F,
Representative electronmicrographs of ipsilateral (C,D) and contralateral (E,F ) immunogold labeling of2-1 in thedorsal horn
(lamina I–III) of L4 and L5 spinal cord sections 14 d after SNL. Scale bar, 0.5m. Arrowheads, Presynaptic sites at the plasma
membrane of excitatory axon terminal boutons (b, characterized by their round synaptic vesicles and opposing postsynaptic
density); arrows, postsynaptic sites at the extrasynaptic plasmamembrane of dendritic shafts (Den); double arrows, intracellular
dendritic sites. For clarity, not all immunoparticles are labeled. G, Ratio of presynaptic to postsynaptic number of particles in the
ipsilateral (filled bars) and contralateral (open bars) L4 and L5 spinal cord dorsal horn. H, Paw withdrawal frequencies to an
innocuousmechanical stimulus (von Frey 6 g) applied to the ipsilateral hindpaw of SNL plus saline- (blue squares; n 12) or SNL
plus PGB-treated animals (red circles; n 11). Error bars represent SEM. Statistical analysis was as follows: nonparametric
Mann–Whitney U test, *p 0.05. Rats were injectedwith PGB or saline starting at day 1 after SNL (day 0, dotted line) and killed
at day 9. I, Normalized fluorescence intensity profiles of ipsi L5 saline- (blue line; n 13), contra L5 saline- (black line; n 13),
ipsi L5 PGB- (red line; n 16), and contra L5 PGB-treated (gray line; n 16) dorsal horn regions. I, Inset, Ipsilateral 2-1
increase compared with contralateral side at 100 m (lam II) in L4–L6 dorsal horn after saline (blue bars) or PGB (red bars)
injections. Error bars represent SEM. Statistical analysis was as follows: nonpaired Student’s t test comparing saline to PGB
treatment, ***p 0.001; **p 0.01. Number of sections is given above bars.
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stricted to the nerve terminals in the spinal cord but was also
evident in the axons of DRG neurons in the dorsal root (Fig. 2A).
EM analysis showed that the vast majority of 2-1 immunopar-
ticles was colocalized with tubulovesicular structures that are in-
volved in protein trafficking, within both myelinated and non-
myelinated axons in L4 and L5 spinal nerves (Fig. 2B–E).
Immunoparticles at the plasma membrane were rarely observed.
L4 axons from SNL animals had a similar number of 2-1 im-
munoparticles on the ipsilateral compared with the contralateral
side (Fig. 2B,D; quantified in F). In contrast, after SNL, the im-
munoparticle density in the ipsilateral L5
spinal nerves was markedly increased
compared with contralateral axons (Fig.
2C,E; quantified in F). Similar EM results
were obtained from L6 spinal nerves (data
not shown).
Chronic pregabalin reduces the
elevation of2-1 in the ipsilateral
fasciculus gracilis
As shown in Figure 2G, after SNL, we
found substantially more 2-1 immuno-
staining in the ipsilateral L5 fasciculus gra-
cilis (fg, arrow) compared with the con-
tralateral side. The fasciculus gracilis, as
part of the dorsal column, contains as-
cending DRG axons and consequently
showed strong 2-1 immunoreactivity
rostrally from L4 (Fig. 2G, inset) through
the cervical C1 region (Fig. 2H) up into the
brainstem (Fig. 2 I). In contrast, there was
no effect of SNL on 2-1 immunostain-
ing in the descending dorsal corticospinal
tract (dcs) (Fig. 2G).
Chronic PGB significantly reduced the
SNL-mediated unilateral 2-1 upregula-
tion in the axons of the fasciculus gracilis.
Whennormalized to the contralateral side,
the ipsilateral fluorescence density in the
fasciculus gracilis in C1 sections after SNL
plus saline treatment was 132  1% (n 
7) comparedwith 123 1%after SNLplus
PGB (n 7; p 0.00005, nonpaired Stu-
dent’s t test).
Upregulation of2-1 mRNA in DRGs
after SNL is not affected by chronic PGB
We wanted to determine whether the ef-
fect of PGB was attributable to decreased
2-1 transcription or translation in
DRGs, or an effect on trafficking. After
SNL, the 2-1 mRNA level was signifi-
cantly upregulated by 	500% 7 and 14 d
after SNL in ligated L5/L6 DRGs, com-
pared with L5/L6 DRGs from sham-
operated animals (Fig. 3A). In contrast,
2-2 mRNA was significantly downregu-
lated in ipsilateral L5/L6 DRGs by 70%,
at 7 and 14 d after SNL (Fig. 3B). Also,
2-3mRNAwas similarly downregulated
14 d after SNL by 61 9% (n 4). These
results emphasize the dominant role of
2-1 over 2-2, which also binds gabap-
entinoid drugs, and 2-3, which does not bind these drugs, in
the development and treatment of neuropathic pain. In contrast,
the mRNA levels for 2-1, 2-2, and 2-3 were not signifi-
cantly changed in ipsilateral L4 DRGs from SNL- and sham-
operated animals (supplemental Fig. 4A, available at www.jneu-
rosci.org as supplemental material) (data not shown).
To investigate the mode of action of chronic PGB, we exam-
ined2-1mRNA levels in L5/L6DRGs fromSNLplus saline and
SNL plus PGB-treated animals. We found that the ipsilateral
2-1 mRNA level was also significantly upregulated by	500%
Figure 2. 2-1 is increased in dorsal roots after SNL and in the ipsilateral ascending tracts from the level of SNL to the
brainstem. A, Z-projection of 10 optical sections of the ipsilateral (left) and contralateral (right) proximal L5 dorsal root.2-1
Immunofluorescence, Green; nuclear staining, blue. Scale bar, 20m. B–E, Electron micrographs of ipsilateral (B, C) and con-
tralateral (D, E) L4 and L5 DRG axons.2-1 immunoparticles at intracellular membranes (arrow) in myelinated (m) and non-
myelinated axons (ax). Scale bar, 0.5m.F, Quantification of immunoparticles (10 2 particles/100m2) in ipsilateral (filled bars)
and contralateral (open bars) L4 and L5 DRG axons. G, H,2-1 immunoperoxidase staining in lumbar L5 (G), L4 (G, inset), and
cervical C1 (H ) spinal cord sections, 14 d after SNL. I,2-1 Immunostaining in the brainstem (approximately bregma14.40),
14 d after SNL. Scale bars, 200m. Arrows,2-1 staining in the ipsilateral fasciculus gracilis (fg); dcs, dorsal corticospinal tract;
cu, cuneate fasciculus; ng, nucleus gracilis.
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in SNL plus saline animals (Fig. 3A). Chronic PGB had no effect
on this elevation (Fig. 3A), indicating that the gene expression of
2-1 was not affected.
Upregulation of2-1 in all size groups of DRG somata after
SNL is mainly intracellular and is not affected by chronic PGB
The ipsilateral ligation-mediated increase of 2-1 mRNA was
reflected in a10-fold increase of 2-1 protein in L5/L6 DRGs
compared with contralateral L4–L6 and ipsilateral L4 DRGs as
measured byWestern blotting (supplemental Fig. 4B, available at
www.jneurosci.org as supplemental material). In contrast, 2-2
protein was not detectable (data not shown).
At the cellular level, DRG somata, characterized by dimly stained
large nuclei, exhibited a wide range of positive 2-1 immunofluo-
rescence, whereas satellite cells with brightly stained smaller nuclei
did not show 2-1 immunofluorescence (Fig. 4A; supplemental
Figs. 4C, 5A, available at www.jneurosci.org as supplemental mate-
rial). After SNL, the 2-1 immunoreactivity was significantly in-
creased inall ipsilateralL5 (Fig. 4A, left panel) (quantified inFig. 4B)
and L6 (data not shown) somata, independent of their size. DRG
neurons with small and medium-sized somata are mainly nocicep-
tors, whereas non-nociceptive neurons have a large soma (Newton
et al., 2001). In addition to the2-1 increase at the level of ligation,
in ipsilateralL4,13%of small somatawere significantlybrighter than
the contralateralmaximum fluorescence density (supplemental Fig.
4C,D, available at www.jneurosci.org as supplemental material).
However, this effect was a result of the surgery, rather than the liga-
tion, since 23% of small ipsilateral L4 DRG somata from sham-
operated animals showed a similar increase in 2-1 immunofluo-
rescence (supplemental Fig. 5A,B, available atwww.jneurosci.org as
supplemental material).
EM images from ipsilateral and contralateral L4 and L5 DRGs
from SNL rats show that2-1 wasmainly associated with the ER
(Fig. 4C–J, arrows). However, it was also present at the PM (Fig.
4E,F, I, J, arrowheads).Whereas the number of immunoparticles
associated with the ER or PM was similar on the ipsilateral and
contralateral side in L4 cell bodies (Fig. 4K), in L5, both the
ipsilateral ER and PM localization was increased approximately
fourfold over the contralateral side after SNL (Fig. 4L). Similar
results were obtained from electron micrographs of L6 DRG cell
bodies (data not shown).
Compared with SNL plus saline, PGB had no significant effect
on the level of 2-1 immunofluorescence measured in small,
medium, and large L5 DRG neurons after SNL (Fig. 4M,N),
indicating that it did not alter the somatic 2-1 protein levels of
either nociceptors or non-nociceptors.
Proximal accumulation of2-1 at the ligation site
demonstrates anterograde trafficking
Images from dorsal root regions 2, 4, and 7 d after SNL (Fig.
5A,B) show a gradual increase of the ipsilateral 2-1 immuno-
fluorescence with time indicating increased trafficking of 2-1
protein from the DRG cell body along the axons.
A well established method to determine the direction of ax-
onal protein trafficking is to perturb the trafficking by nerve liga-
tion causing the protein to accumulate at the ligation site. As
shown in Figure 5C, there was a much stronger immunofluores-
cence staining of 2-1 at the proximal compared with the distal
side 4 d after SNL. A similar accumulation of 2-1 was observed
2 d after ligation (data not shown). This indicates that 2-1 was
trafficked anterogradely originating from the DRG cell bodies.
The gradual accumulation of2-1 along the spinal nerve toward
the ligation site (Fig. 5C) was absent on the nonligated contralat-
eral side (Fig. 5D). The proximal accumulation of 2-1 was
confirmed by immunoblotting of proteins extracted from ipsilat-
eral L5 spinal nerve, dorsal root segments andDRGs 4 d after SNL
(Fig. 5E). For quantification, spinal nerve and dorsal root protein
levels were normalized to the level of 2-1 protein detected in
DRGs (100%) (Fig. 5F, lane 5). SNL caused 2-1 to accumu-
late at the proximal ligation site to a similar level to that found in
DRGs (Fig. 5F, lane 3) (100  8%; n  8), whereas at the distal
ligation site the level of2-1 protein wasmuch lower (only 35
15%of theDRGprotein level) (Fig. 5F, lane 2). The2-1 protein
in DRGs had a slightly higher molecular weight than the traf-
ficked protein detected in the adjacent spinal nerves and dorsal
roots. A similar difference in themolecular weight between2-1
protein in DRGs and 2-1 isolated from spinal cord tissue was
previously identified as a difference in protein glycosylation (Luo
et al., 2001). Chronic application of PGB for 3.5 d reduced the
accumulation of 2-1 at the site proximal to the ligation of the
spinal nerve compared with the accumulation in saline-injected
animals. We found that, after PGB injections, the 2-1 protein
level at the proximal ligation site was reduced by 24 and 32%
compared with saline-injected animals (tissue pooled from two
to four animals processed in two independent experiments).
Figure 3. Upregulation of2-1 mRNA after SNL is not affected by chronic PGB. A, Q-PCR
results for2-1 mRNA levels (percentage) in pooled ipsilateral L5/L6 DRGs (ipsi 5 6) from
sham-operated animals (open bars; n 5), from animals 7 d (n 4; gray bars) or 14 d (n 7;
black bars) after SNL and from SNL plus saline (horizontal striped bar; n 4) or SNL plus PGB
animals (hatched bar; n 4). Data are normalized to the respective contralateral side. Error
bars represent SEM. Statistical analysis was as follows: one-way ANOVAwith p 0.0031 using
SNK post test: **p 0.01; *p 0.05. Note: Increase in SNL plus PGB animals was not signifi-
cantly different from SNL plus saline animals in SNK post test ( p	 0.05). B, Q-PCR results for
2-2 mRNA levels (percentage) in pooled ipsilateral L5/L6 DRGs (ipsi 5 6) from either
sham-operated animals (open bars, n 5) or from animals 7 d (n 4; gray bars) or 14 d (n
7; black bars) after SNL. Data are normalized to the respective contralateral side. Error bars
represent SEM. Statistical analysis was as follows: one-way ANOVAwith p 0.0001 using SNK
post test, ***p 0.001.
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Figure4. SNL-mediated ipsilateral increase of2-1 protein levels inDRG somata is not affectedby chronic PGB.A, Single images of ipsilateral (left) and contralateral (right) L5DRG sections 14d
after ligation.2-1 Immunofluorescence, Green; nuclear staining, blue. Scale bar, 20m. B, Mean intracellular FD [in arbitrary units (a.u.) per square micrometer] of ipsilateral (filled bars) and
contralateral (open bars) small (700 m2), medium (700–1100 m2), and large (	1100 m2) DRG somata 14 d after SNL. Error bars represent SEM. Statistical analysis was as follows:
nonpaired Student’s t test comparing ipsilateral to contralateral side, ***p 0.001. Numbers of cells are given above bars. C–J, Electron micrographs of ipsilateral L4 (C) and L5 (D) DRG somata
adjacent to the nucleus (N) and PM [L4 (E); L5 (F )] 14 d after ligation. Immunoparticles for 2-1 are mainly associated with the ER (arrows) and also at PM (arrowheads). Micrographs of
contralateral L4 (G) and L5 (H ) DRG somata and PM [L4 (I ); L5 (J )]. Scale bar, 0.5m. For clarity, not all immunoparticles are labeled. K, L, Quantification of immunoparticle density in the ER
(particles/100m2; left) and number of particles at the PM (particles/100m; right) in ipsilateral (filled bars) and contralateral (open bars) L4 and L5 DRG somata.M, Images of ipsilateral L5 DRG
sections fromSNLplus saline or SNL plus PGB animals.2-1 Immunofluorescence, Green; nuclear staining, blue. Scale bar, 20m.N, Normalized fluorescence density (FDNORM) of ipsilateral small,
medium, and large DRG somata after SNL plus saline (blue bars) or SNL plus PGB treatment (red bars). Data are normalized to mean FD of respective SNL plus saline size group. Error bars represent
SEM. Statistical analysis was as follows: nonpaired Student’s t test comparing saline to PGB treatment, p 0.417 for small; p 0.801 formedium; p 0.223 for large cell bodies. Numbers of cells
analyzed are given above bars.
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Pregabalin reduces the2-1 level at the
plasmamembrane without
affecting endocytosis
We next probed in vitro the mechanism of
action of PGB, by examining whether PGB
caused a reduction of 2-1 trafficking as
determined by expression at the plasma
membrane. First, we characterized the
properties of the anti-2-1 antibody used
for this purpose. Figure 6A shows a repre-
sentative image of the intracellular distri-
bution of 2-1 in transfected and perme-
abilized Cos-7 cells (green staining) also
expressing Cav2.2 and 1b to mimic the
native calcium channel composition
found in DRGs. In nonpermeabilized cells
(Fig. 6B), 2-1 is detected in the plasma
membrane indicating that the antibody
recognizes an extracellular epitope of2-1.
To confirm the specificity of the antibody,
cells simultaneously probed with anti-
2-2 (red) and anti-2-1 antibody while
expressing 2-2 (Fig. 6C) showed only
2-2 staining. As shown in Figure 6D–F,
cell surface expression of 2-1 was mea-
sured in nonpermeabilized Cos-7 cells.
Omission of the primary antibody served
as a negative control (Fig. 6G). Application
of 20 or 200 M PGB, for 72 h after trans-
fection, reduced plasma membrane im-
munofluorescence of 2-1 (Fig. 6E,F) by
40 and 65%, respectively (Fig. 6H),
when compared with saline-treated con-
trol cells (Fig. 6D,H).
Although this result agrees with our in
vivo findings in the spinal cord (Fig. 1 I),
both could, in principle, be attributable ei-
ther to a reduction of anterograde traffick-
ing or to an increase in endocytosis of
2-1 subunits by PGB. To examine a pos-
sible effect of chronic PGB on endocytosis,
nonpermeabilized living Cos-7 cells ex-
pressing 2-1 (together with Cav2.2 and
1b) were incubated at 72 h posttransfec-
tion with 2-1 antibody at 37°C for 2.5 h,
allowing endocytosis to occur. They were
then fixed and all remaining cell surface
2-1 was saturated with a secondary an-
tibody (red). After permeabilization, en-
docytosed 2-1 was then labeled (Fig.
6 I, J, green). To quantify endocytosis, the
Figure5. Increase of2-1 proteinwith time in dorsal roots and accumulation proximal to the ligation site.A, Representative
single images of contralateral L5 dorsal roots 2 d (left), 4 d (middle), and 7 d after SNL (right). B, Representative single images of
ipsilateral L5 dorsal roots 2 d (left), 4 d (middle), and 7 d after SNL. 2-1 Immunofluorescence, Green. Scale bar, 200m. C,
Single image of an ipsilateral L5 spinal nerve and DRG section 4 d after ligation. 2-1 Immunofluorescence, Green; outline,
white; tissue boundaries determined with nuclear staining (data not shown). Scale bar, 1 mm. D, Single image of a contralateral
L5 spinal nerve and DRG section 4 d after ligation.2-1 Immunofluorescence, Green; outline, white; tissue boundaries deter-
mined with nuclear staining (data not shown). Scale bar, 1 mm. Note: Stronger 2-1 staining in the ipsilateral DRG neuron
somata comparedwith the contralateral side. E, Top, Diagram of ipsilateral L5 spinal nerve showing ligation site, DRG, and dorsal
root segments used for Western blotting. Middle, Representative immunoblot of 2-1 expression in spinal nerve segments
4
(lanes 1–4 with ligation site marked with X between lanes 2
and 3), DRG (lane 5), and dorsal root segments (lane 6 and 7)
pooled from four animals 4 d after ligation. Bottom, Corre-
sponding immunoblot of GAPDH expression in ipsilateral L5
spinal nerve, DRG, and dorsal root tissue. F, Quantification of
three immunoblots of 2-1 expression in pooled spinal
nerve and dorsal root segments 4 d after SNL corrected for gel
loading (GAPDH protein level) and normalized to the2-1
level in theDRGs (number of tissue segments in parentheses).
Error bars represent SEM.
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ratio of internal fluorescence density/total fluorescence density
was calculated. In control cells (saline-treated; n 20), 15 2%
of2-1 was endocytosed in 2.5 h, indicating that2-1 is subject
to constitutive endocytosis. However, when PGB (200 M) was
present in the medium from the time of transfection and during
the endocytosis period, it had no signifi-
cant effect on the amount of constitutive
endocytosis (20 4%; n 20; p 0.2187,
nonpaired Student’s t test). Essentially the
same results were obtained using 2-2
and up to 1 mM gabapentin (data not
shown), reinforcing the view that the
gabapentinoid 2 ligands do not act by
enhancing endocytosis of calcium
channels.
Discussion
Our data provide a possible explanation of
how chronic application of PGB can alle-
viate neuropathic pain by reducing an-
terograde trafficking and consequently re-
ducing the level of presynaptic 2-1 in
nerve terminals in the spinal cord.
After SNL, we found that the elevation
of 2-1 protein in DRGs occurs through-
out the cytoplasm in all DRG cell subtypes,
as also shown for 2-1 mRNA after par-
tial sciatic nerve injury (Newton et al.,
2001) and in diabetic neuropathy (Yusaf et
al., 2001). However, in contrast to mRNA
levels, the detection and quantification of
2-1 protein provides a more functional
assessment. Previous studies have shown
an upregulation of 2-1 protein in DRGs
and spinal cord using immunoblotting or
3H-gabapentinoid binding, but those ap-
proaches lack cellular and subcellular res-
olution (Luo et al., 2001; Field et al., 2006;
Melrose et al., 2007). Using immunohisto-
chemistry, we were able to detect small
changes in subpopulations of cells that
would be undetected by other methods.
Moreover, our ultrastructural analysis en-
abled us to determine the subcellular local-
ization of upregulated 2-1 protein in
DRG somata and axons asmainly intracel-
lular, being mainly within the ER in cell
bodies and associated with tubular-
vesicular structures involved in protein
trafficking in the dorsal root.
The upregulation of 2-1 in the spinal
cord is critical for the initiation and main-
tenance of neuropathic pain (Boroujerdi
et al., 2008). We found a highly significant
presynaptic increase of 2-1 in the nerve
terminals of DRG neurons that innervate
the superficial and deeper layers of the
dorsal horn. Almost no 2-1 immuno-
particles were observed to be associated
with inhibitory terminals, and this labeling
was not increased after SNL. Moreover,
there was no increase in 2-1 mRNA in
dorsal horn neuronswithin the spinal cord
after SNL. Therefore, our EM and quanti-
tative RT-PCR results are the first direct evidence that the 2-1
elevation after SNL occurs exclusively in presynaptic terminals of
primary sensory afferents, whereas previous studies have relied
onmore indirectmethods to interpret the increase of2-1 in the
Figure6. PGB reduces cell surface expression but does not affect endocytosis of2-1.A–C, Localization of exogenous2-1
in Cos-7 cells that were either permeabilized (A) or nonpermeabilized (B) before immunostaining with anti-2-1 antibody
(green). C, Staining for exogenous 2-2 in permeabilized Cos-7 cells with anti-2-2 antibody (red) in presence of the anti-
2-1 antibody (green). Nuclear staining, Blue. Note: Lack of green staining indicates lack of cross-reactivity of the anti-2-1
antibody. Scale bar, 20m. D–F, Images of surface expression of2-1 (green) in nonpermeabilized Cos-7 cells treated with 0
(saline; D), 20 (E) or 200 (F )M PGB for 72 h. G, No primary antibody. Nuclear staining, Blue. Scale bar, 20m. H, Normalized
fluorescence densities (FDNORM) after saline (blue bar) and 20 or 200M PGB treatment (red bars). FDs were normalized to the
mean FD of saline-treated cells. Error bars represent SEM. Statistical analysis was as follows: one-way ANOVA, p 0.0001, with
Bonferroni’s post test, *p 0.05 and ***p 0.001. Number of cells examined is given above bars. I, J, Images of 2-1
endocytosis assay in Cos-7 cells performed in absence (saline; I ) or presence of 200 M PGB (J ). Cell surface 2-1, Red;
internalized2-1, green; nuclear staining, blue. Scale bar, 20m.
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dorsal horn (Wang et al., 2002; Li et al., 2004). The majority of
unmyelinated nociceptive primary afferents synapse mainly in
lamina I and II of the dorsal hornwithin the same spinal segment.
However, a proportion of afferents project in Lissauer’s tract to
up to two spinal segments rostrally and one spinal segment cau-
dally. The L4 dorsal horn not only receives afferents from L4, but
also from ligated L5/L6 dorsal roots (Besse et al., 1991; Shehab et
al., 2008). This may contribute to the small, but statistically sig-
nificant elevation of 2-1 in ipsilateral L4 after SNL.
Small-diameter, unmyelinated C-fibers convey thermal hy-
peralgesia, whereas tactile allodynia is transmitted mainly
through large-diameter A afferent fibers (Sun et al., 2001;
Pitcher and Henry, 2004). As well as terminating in deeper layers
of the dorsal horn, some myelinated medium and large DRG
neurons, involved in touch and proprioception, send their axons
to the brainstem via the fasciculus gracilis in the dorsal column.
Furthermore, ablation of the ipsilateral dorsal column in SNL
rats blocks tactile allodynia (Sun et al., 2001). Accordingly, we
found that 2-1 immunoreactivity was elevated unilaterally in
this ascending tract, at all levels above the ligation, in agreement
with our finding that 2-1 is elevated in all DRG cell subtypes.
Tactile allodynia may be linked to increased activity in this as-
cending pathway to supraspinal sites (Sun et al., 2001), whereas
thermal hyperalgesia may be mediated through local spinal cir-
cuitry (Miki et al., 2000).
Spinal voltage-gated calcium channels are important targets
in the treatment of pain (Snutch, 2005). Upregulation of2-1 in
the spinal cord is thought to increase presynaptic Ca2 influx and
neurotransmitter release, therefore sensitizing the spinal cord, an
important component of neuropathic pain. Furthermore, the
ability of the 2 ligand drugs to alleviate neuropathic pain is
thought to be causally related to the elevation of 2-1 in injured
DRGs after nerve ligation (for review, see Cheng and Chiou,
2006). In several neuropathic pain models, gabapentin was able
to reduce transmitter release or excitatory synaptic transmission
in the spinal cord (Patel et al., 2000; Coderre et al., 2005). How-
ever, in other studies in naive animals, either no acute effects of
gabapentin were found on spontaneous synaptic currents in lam-
ina II neurons (Moore et al., 2002), or gabapentin reduced both
inhibitory and excitatory transmission in the mouse spinal cord
dorsal horn through a preferential block only of P/Q-type Ca2
channels (Bayer et al., 2004). Therefore, the mode of action of
gabapentin is still under debate. A key finding of this study is that
the ipsilateral presynaptic elevation of 2-1 in the dorsal horn
after SNL was very substantially and significantly reduced by
chronic PGB, at a dose sufficient to reverse the behavioral mani-
festations of SNL. Furthermore, there was also less elevation of
2-1 in the ipsilateral axons of the fasciculus gracilis, an obser-
vation that may be relevant to explain the antiallodynic effect of
PGB.
In contrast, we found no effect of chronic PGB treatment on
2-1 mRNA and protein levels in DRG cell bodies. This indi-
cates that it is not the expression of2-1, but its trafficking from
the DRG cell bodies to the presynaptic terminals that is affected
by PGB. However, our finding that 2-2 and 2-3 mRNA are
substantially downregulated in SNL suggests that 2-1 may also
substitute for these species in SNL, potentially increasing the sen-
sitivity to gabapentinoid drugs.
Acute inhibitory effects of gabapentinoid drugs on transmit-
ter release and synaptic transmissionhave been observed in some,
but not all in vitro systems (for review, seeDavies et al., 2007). For
example, in the trigeminal nucleus, an effect of gabapentin was
only observed on a component of transmitter release that was
enhanced after protein kinase C activation (Maneuf and McK-
night, 2001). Related to this, it has been shown that calcium
channel insertion into the plasmamembrane is enhanced by pro-
tein kinase C activation (Zhang et al., 2008).
In all behavioral measures of tactile allodynia presented here,
there was an increasing antiallodynic effect of PGB over the pe-
riod of treatment. Cold allodynia was only significantly attenu-
ated after 7 d of PGB administration. Although the behavioral
therapeutic effects of gabapentinoid drugs are often observed
acutely (Field et al., 2006), this is not always the case (Hao et al.,
2000; Fox et al., 2003; Xiao et al., 2007). It has also been shown
that gabapentin is ineffective acutely if administered after, rather
than before, a traumatic insult, such as intraplantar formalin
injection (Yoon and Yaksh, 1999). This has been interpreted as
gabapentin preventing the initiation of an upregulated persistent
pain state, which would translate in the patient to an antihyper-
algesic action of this drug occurring after a delay, whose duration
would depend on the nature of the persistent injury and the rate
of turnover of the “facilitatory cascade” associated with the pain
state (Yoon and Yaksh, 1999). Consequently, it is possible that
these drugs have acute effects on synaptic transmission under
certain conditions, as well as the effects described here to counter
the SNL-induced elevation of 2-1 in injured DRG axons and
presynaptic terminals. Indeed, facilitatory spinal cord–brain–
spinal cord circuits (Suzuki et al., 2004) have been shown to
rapidly induce a permissive state-dependency for gabapentin in
naive animals, through a descending facilitatory spinal
5-hydroxytryptamine receptor-mediated pathway, that could
mediate the fast-onset effects of 2 ligands (Suzuki et al., 2005).
One can envisage a scenario after SNL, whereby both the eleva-
tion of presynaptic 2-1 and the release of mediators in the
dorsal horn (for review, see Svensson and Yaksh, 2002) exercise a
concerted effect to increase calcium channel insertion into pre-
synaptic terminals and to enhance transmitter release. Thus,
gabapentinoid drugsmight actmore or less rapidly depending on
the interplay between these different elements.
Chronic PGB application dramatically reduced the cell sur-
face expression of 2-1 in vitro without affecting constitutive
endocytosis. The observed constitutive endocytosis agrees with
the relatively high proportion of postsynaptic 2-1 in the spinal
cord electron micrographs that was present in intracellular vesi-
cles. Related to this, we have shown that both2-1 and2-2 are
present in cholesterol-rich lipid raft fractions (Davies et al.,
2006), which are associatedwith the endocytoticmachinery (Gle-
bov et al., 2006).
Our recent work has suggested that 2 subunits have an ef-
fect on calcium channel trafficking via the Von Willebrand
factor-A domain in the 2 subunit (Cantí et al., 2005), and fur-
thermore, gabapentinoid drugs exert their effects intracellularly
to disrupt the process of2 trafficking (Hendrich et al., 2008). In
that study, because of the reduced trafficking shown by the mu-
tant R217A-2-1 and R282A-2-2, which do not bind gabap-
entin, we speculated that these drugs may displace an endoge-
nous small molecule ligand that might be important for correct
trafficking of these2 subunits (Heblich et al., 2008;Hendrich et
al., 2008). Little is known about the trafficking of 2-1, and
indeed the images of2-1 accumulation proximal to the ligation
site and the localization in axonal tubulovesicular structures rep-
resent the first direct evidence for 2-1 trafficking.
In conclusion, this study supports the hypothesis that 2-1
subunits are involved in trafficking of calcium channels from the
site of synthesis to the plasma membrane of the presynaptic ter-
minals. Both our in vivo and in vitro data point to the gabapentin-
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oid drugs inhibiting this process in neuropathic pain,making this
a unique mode of action, contrasting with the direct cell surface
effects of other drugs used in this condition.
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